These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 25742619)
21. Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: Plausible roles of p53, MAPK and AKT pathways. Mantawy EM; Esmat A; El-Bakly WM; Salah ElDin RA; El-Demerdash E Sci Rep; 2017 Jul; 7(1):4795. PubMed ID: 28684738 [TBL] [Abstract][Full Text] [Related]
22. Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice. Nozaki N; Shishido T; Takeishi Y; Kubota I Circulation; 2004 Nov; 110(18):2869-74. PubMed ID: 15505089 [TBL] [Abstract][Full Text] [Related]
23. Pretreatment with statin attenuates the cardiotoxicity of Doxorubicin in mice. Riad A; Bien S; Westermann D; Becher PM; Loya K; Landmesser U; Kroemer HK; Schultheiss HP; Tschöpe C Cancer Res; 2009 Jan; 69(2):695-9. PubMed ID: 19147586 [TBL] [Abstract][Full Text] [Related]
24. Schisandrin B reverses doxorubicin resistance through inhibiting P-glycoprotein and promoting proteasome-mediated degradation of survivin. Wang S; Wang A; Shao M; Lin L; Li P; Wang Y Sci Rep; 2017 Aug; 7(1):8419. PubMed ID: 28827665 [TBL] [Abstract][Full Text] [Related]
25. Schisandrin B prevents doxorubicin-induced cardiotoxicity via enhancing glutathione redox cycling. Li L; Pan Q; Han W; Liu Z; Li L; Hu X Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6753-60. PubMed ID: 18006777 [TBL] [Abstract][Full Text] [Related]
26. Schisandrin B exerts anti-neuroinflammatory activity by inhibiting the Toll-like receptor 4-dependent MyD88/IKK/NF-κB signaling pathway in lipopolysaccharide-induced microglia. Zeng KW; Zhang T; Fu H; Liu GX; Wang XM Eur J Pharmacol; 2012 Oct; 692(1-3):29-37. PubMed ID: 22698579 [TBL] [Abstract][Full Text] [Related]
27. Anti-inflammatory effects of schisandrin isolated from the fruit of Schisandra chinensis Baill. Guo LY; Hung TM; Bae KH; Shin EM; Zhou HY; Hong YN; Kang SS; Kim HP; Kim YS Eur J Pharmacol; 2008 Sep; 591(1-3):293-9. PubMed ID: 18625216 [TBL] [Abstract][Full Text] [Related]
28. Schisandrin B attenuates CCl Chen Q; Zhang H; Cao Y; Li Y; Sun S; Zhang J; Zhang G Drug Des Devel Ther; 2017; 11():2179-2191. PubMed ID: 28794616 [TBL] [Abstract][Full Text] [Related]
29. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis. Mantawy EM; El-Bakly WM; Esmat A; Badr AM; El-Demerdash E Eur J Pharmacol; 2014 Apr; 728():107-18. PubMed ID: 24509133 [TBL] [Abstract][Full Text] [Related]
30. Prevention of scopolamine-induced memory deficits by schisandrin B, an antioxidant lignan from Schisandra chinensis in mice. Giridharan VV; Thandavarayan RA; Sato S; Ko KM; Konishi T Free Radic Res; 2011 Aug; 45(8):950-8. PubMed ID: 21615274 [TBL] [Abstract][Full Text] [Related]
31. Schisandrin B attenuates acetaminophen-induced hepatic injury through heat-shock protein 27 and 70 in mice. Li L; Zhang T; Zhou L; Zhou L; Xing G; Chen Y; Xin Y J Gastroenterol Hepatol; 2014 Mar; 29(3):640-7. PubMed ID: 24219791 [TBL] [Abstract][Full Text] [Related]
32. Anti-Inflammatory Effects of Schisandrin B on LPS-Stimulated BV2 Microglia via Activating PPAR-γ. Liu N; Zheng JX; Zhuang YS; Zhou ZK; Zhao JH; Yang L Inflammation; 2017 Jun; 40(3):1006-1011. PubMed ID: 28303415 [TBL] [Abstract][Full Text] [Related]
33. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4. Mohamed HE; Asker ME; Ali SI; el-Fattah TM J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041 [TBL] [Abstract][Full Text] [Related]
34. Comparative effects of schisandrin A, B, and C on Propionibacterium acnes-induced, NLRP3 inflammasome activation-mediated IL-1β secretion and pyroptosis. Guo M; An F; Yu H; Wei X; Hong M; Lu Y Biomed Pharmacother; 2017 Dec; 96():129-136. PubMed ID: 28972885 [TBL] [Abstract][Full Text] [Related]
35. Synergistic protection of Schizandrin B and Glycyrrhizic acid against bleomycin-induced pulmonary fibrosis by inhibiting TGF-β1/Smad2 pathways and overexpression of NOX4. Zhang D; Liu B; Cao B; Wei F; Yu X; Li GF; Chen H; Wei LQ; Wang PL Int Immunopharmacol; 2017 Jul; 48():67-75. PubMed ID: 28476015 [TBL] [Abstract][Full Text] [Related]
36. Schisandrin C targets Keap1 and attenuates oxidative stress by activating Nrf2 pathway in Ang II-challenged vascular endothelium. Han J; Shi X; Du Y; Shi F; Zhang B; Zheng Z; Xu J; Jiang L Phytother Res; 2019 Mar; 33(3):779-790. PubMed ID: 30632210 [TBL] [Abstract][Full Text] [Related]
37. Schisandrin A prevents oxidative stress-induced DNA damage and apoptosis by attenuating ROS generation in C2C12 cells. Choi YH Biomed Pharmacother; 2018 Oct; 106():902-909. PubMed ID: 30119261 [TBL] [Abstract][Full Text] [Related]
38. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway. Kim KH; Oudit GY; Backx PH J Pharmacol Exp Ther; 2008 Jan; 324(1):160-9. PubMed ID: 17928571 [TBL] [Abstract][Full Text] [Related]
39. Gomisin N Alleviates Ethanol-Induced Liver Injury through Ameliorating Lipid Metabolism and Oxidative Stress. Nagappan A; Jung DY; Kim JH; Lee H; Jung MH Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200508 [TBL] [Abstract][Full Text] [Related]
40. Schisandrin B alleviates angiotensin II-induced cardiac inflammatory remodeling by inhibiting the recruitment of MyD88 to TLRs in mouse cardiomyocytes. Xu S; Hu C; Han J; Luo W; Huang L; Jiang Y; Samorodov AV; Wang Y; Huang J Int Immunopharmacol; 2024 Sep; 139():112660. PubMed ID: 39018688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]